Reproterol
Systematic (IUPAC) name | |
---|---|
(RS)-7-(3-{[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino}propyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
54063-54-6 | |
R03AC15 | |
PubChem | CID 25654 |
ChemSpider | 23898 |
UNII | 11941YC6RN |
KEGG | D08474 |
ChEMBL | CHEMBL1095607 |
Chemical data | |
Formula | C18H23N5O5 |
389.406 g/mol | |
SMILES
| |
| |
(what is this?) (verify) |
Reproterol (INN) is a β2-adrenergic receptor agonist used in the treatment of asthma.[1]
References
- ↑ Virchow JC Jr. Reproterol: beta-2-agonist, theophylline, or both? Respiration. 1999;66(3):210-1. PMID 10364735
|